Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05271578 · ClinicalTrials.gov registry record · NA
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT05271578: Completed NA study, sponsored by University of Pennsylvania.
NCT05271578 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05271578, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
To examine vascular reactivity and inflammatory biomarkers via quantitative magnetic resonance imaging (MRI) and blood serum, respectively, in a crossover study where active vapers (electronic cigarette users) and smokers will undergo three separate acute exposure-episodes of electronic cigarette +/- nicotine and tobacco-cig. The MRI exams and blood draws will be performed pre- and post-exposure. The results will be compared against baseline values derived from a group of non-smokers/non-vapers, who will also undergo a blood draw and MRI.
Interventions
- DEVICE Standardized Electronic Research Cigarette
- DEVICE Nicotine Research Cigarette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2022-06-07 |
| Est. Completion | 2025-11-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05271578
The ClinicalTrials.gov registry entry for NCT05271578 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standardized Electronic Research Cigarette is the first listed.
NCT05271578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05271578 about?
NCT05271578 is a clinical study titled "MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers". To examine vascular reactivity and inflammatory biomarkers via quantitative magnetic resonance imaging (MRI) and blood serum, respectively, in a crossover study where active vapers (electronic cigarette users) and smokers will undergo three separate acute exposure-episodes of electronic cigarette +/...
What is the current status of trial NCT05271578?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2022-06-07. Estimated completion is 2025-11-28.
What interventions are being tested in trial NCT05271578?
The interventions under investigation include: Standardized Electronic Research Cigarette (DEVICE), Nicotine Research Cigarette (DEVICE).
Who is sponsoring clinical trial NCT05271578?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.